Profile-

Dedicated to lVD Solutions Globally | Since 1992

Guangzhou Wondfo Biotech Co., Ltd. founded in 1992 and headquartered in Guangzhou science city. Wondfo focuses on the R&D, manufacturing, sales and service of IVD industry, providing professional rapid diagnosis and chronic disease management solutions.
Wondfo has 9 technology platforms. Our rapid diagnostic devices and reagents span a wide spectrum, including cardiovascular diseases, diabetes, renal functions, respiratory issues, fertility, DOA, infections, tumors, etc. We provide services to over 150 countries and regions.
In 2015, Wondfo was listed on the Shenzhen Stock Exchange, becoming the first public company in POCT in China.

Sound Product System

Continuous innovation drives us forward. Wondfo has developed “9 Technology Platforms”- the immune colloidal gold, immune-fluorescence, electrochemistry, dry biochemistry, chemiluminescence, molecular diagnostics, instrument, pathology, and biological raw material.

Based on the above technology platforms, Wondfo has extended the product lines to the rapid identification of cardiovascular diseases, inflammation, tumor, infectious diseases, drug abuse, pregnancy, etc. Our products are widely used in the rapid diagnosis and effective treatment monitoring of critical and severe diseases, chronic disease management, maternal and children healthcare, blood glucose monitoring, drug detection, alcohol testing, forensic expertise and other fields.

The Flu Series is the star product of Wondfo which keeps brilliant records. It is the only product in China obtaining the registration certificate for antigen detection of H7 subtype avian influenza virus. And it is the only influenza detection product in China with a full range of test menu (H7, FIuA, FIuB, FIuA&B).

In recent years, Wondfo launched a molecular diagnostic technology platform for more accurate diagnosis of influenza diseases, infectious diseases, and tumor concomitant.

About Wondfo

Global Ecosphere

In recent years, Wondfo has built a global " Wondfo Ecosystem" and expanded the global coverage of products, technologies and channels by setting joint innovation bases, joint operation centers, and cross-border mergers and acquisitions.

To integrate global research and innovation resources, Wondfo has established research and development centers in San Diego, and Guangzhou, and introduced more than 530 top-notch researchers at home and abroad.

Besides, Wondfo invested in factories in Asia, South America, Africa and the commonwealth of independent states to build a global manufacturing system that helps reduce the delivery time and cost.

As customer satisfaction to be our priority, Wondfo continues to expand the global service network to more efficiently serve customers all over the world. Wondfo has set up more than 20 subsidiaries worldwide, providing products, solutions, and technical support to customers in more than 140 regions and countries.

3000+

Employees
800+

Researchers
150+

Countries / Regions
20+

Subsidiaries

Racing For Life

Wondfo strives for excellence, sticks to the philosophy of "Earn everyone's trust by serving them the best", and makes every effort to meet the expectations of employees, customers, and partners.

Here, everything we do is to safeguard the health and improve the lives of people worldwide. With this in mind, we’ll continue to innovate and shape the future of POCT and healthcare.

Choose your location